SUBLEASE AMENDMENT NO. 1Sublease Amendment • September 2nd, 2016 • Editas Medicine, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledSeptember 2nd, 2016 Company Industry JurisdictionThis Sublease Amendment No. 1 (this “Amendment”) is made as of this 31st day of August, 2016 by and between ALNYLAM PHARMACEUTICALS, INC., a Delaware corporation (“Sublessor”) and EDITAS MEDICINE, INC., a Delaware corporation (“Sublessee”).